In short. Nevus of Ota is a blue-grey birthmark of deep dermal pigment around one eye, sometimes involving the eye surface. Because the melanin sits in the dermis rather than superficially, it looks blue-grey and responds to pigment lasers far better than brown surface pigment does. It is benign, but the eye needs separate assessment.

Key points

  • Deep dermal melanin explains the blue-grey colour and the strong laser response.
  • It is benign: not a tattoo, a bruise, a mole, or cancer.
  • Eye involvement is common and is monitored by an ophthalmologist, not lasered.
  • Treatment is a course of many sessions, months apart, with gradual lightening.
  • Darker skin tones carry a higher risk of temporary darkening after laser.

What it is — and is not

Nevus of Ota is a congenital or early-life birthmark of blue-grey pigmentation around one eye: the temple, eyelid, forehead, and cheek, occasionally involving the white of the eye itself. The pigment sits deep in the skin, and sometimes on the eye's surface. It is present from birth or appears around puberty, and it is far more common in Asian populations. It is benign, but it is one of the conditions where laser treatment genuinely transforms lives.

The colour is blue-grey rather than brown because the pigment is deep dermal melanin. It is not a tattoo, not a bruise, not a mole, and not cancer. Rarely, similar pigment appears as an acquired patch in adulthood; that variant deserves examination to exclude mimics, and eye involvement anywhere in the spectrum warrants a baseline eye assessment.

How is it assessed?

Clinical diagnosis is usually straightforward, supported by dermatoscopy and Wood's lamp. Two questions shape management: how deep and extensive the pigment is, and whether the eye is involved. Eye involvement goes to an ophthalmologist for monitoring. Photography grades extent before treatment.

Finding What it means Next step
Blue-grey patch around one eye Deep dermal melanin, not surface pigment Clinical diagnosis with dermatoscopy and Wood's lamp
Pigment on the white of the eye Common in nevus of Ota Ophthalmology monitoring, not laser
Patch first appearing in adulthood The acquired variant has mimics Examination to exclude them before treatment
Extensive or dark mark Depth and extent shape the plan Photography to grade extent
Eyelid and temple involved Delicate skin, higher treatment demand Conservative settings and eye shielding
Dark skin tone Higher risk of temporary darkening Expert-adjusted settings

The laser pathway

Quality-switched and picosecond pigment lasers target deep dermal pigment selectively, shattering it for the body to clear. Treatment is a course of sessions — typically many, spaced months apart — with gradual lightening rather than instant erasure. Most patients achieve substantial fading; complete clearance is possible in lighter and less extensive marks, though it is not guaranteed.

What does a course of treatment involve?

The eyelid and temple skin is delicate, so settings are conservative and sessions numerous. Periorbital treatment requires eye shielding by protocol. Dark skin tones carry a higher risk of temporary darkening, which expert settings manage.

What happens when the eye is involved?

Pigment on the eye's white is common in nevus of Ota and is monitored rather than lasered. A small association with pressure-raising eye conditions exists, which is why baseline and periodic eye checks are part of care, even when the skin treatment is going beautifully.

When should treatment start?

Skin treatment can begin in childhood for extensive marks; early treatment means fewer school-years of questions. Adult treatment works identically. This is one of the few conditions where patients are routinely shown their own before-and-after photographs and struggle to find the treated side.

When should a change be reviewed rather than treated?

  • A blue-grey patch appears or enlarges in adulthood without prior history; mimics are excluded first.
  • There is eye pain, vision change, or a dark spot growing on the eye itself.
  • Any birthmark changes in a way that breaks its usual pattern.

A changing lesion is examined to exclude malignancy, not treated. Assessment comes before any cosmetic plan, and eye findings belong with an ophthalmologist rather than a laser room.

Sources

Internal links

Frequently asked questions

Is nevus of Ota dangerous?

The pigment is deep dermal melanin and the birthmark is benign. It is not a tattoo, a bruise, a mole or a cancer. Eye involvement is common and is monitored rather than lasered, because a small association with pressure-raising eye conditions exists.

How many laser sessions does nevus of Ota need?

Treatment is a course of sessions, typically many and spaced months apart, with gradual lightening rather than instant erasure. Most patients achieve substantial fading, and complete clearance is possible in lighter and less extensive marks, though it is not guaranteed.

Can nevus of Ota be treated in childhood?

Yes. Skin treatment can begin in childhood for extensive marks, and early treatment means fewer school-years of questions. Adult treatment works identically. The eyelid and temple skin is delicate, so settings are conservative and sessions numerous.

Risks & Limitations

  • Most chronic skin disease is managed rather than cured, and relapse is expected.
  • Treatments typically need 8–12 weeks before response can be judged fairly.
  • Topical treatment can cause irritation, dryness, peeling and photosensitivity.
  • Systemic therapy may require blood monitoring and carries organ, metabolic and pregnancy risks.
  • Isotretinoin in particular requires strict monitoring and pregnancy prevention.
  • Pigment change is often slow and may be incomplete.
  • No treatment works for everyone, and response cannot be predicted with certainty.

When to Seek Care

  • A mole or lesion that changes in size, shape or colour, or starts to bleed, itch or crust.
  • Fever with a widespread rash, blistering, or rash involving the eyes, mouth or genitals — seek emergency care.
  • Rapidly spreading redness, swelling or pain in the skin.
  • Facial swelling or difficulty breathing — possible severe reaction; seek emergency care immediately.
  • New or worsening symptoms while taking a monitored medication.

References & Further Reading

  • American Academy of Dermatology (AAD) — public and clinical guidance
  • World Health Organization (WHO) — skin and infectious disease resources
  • Chinese Medical Association, Dermatology Branch — clinical guidance
  • Cochrane Library — systematic reviews in dermatology

Medically reviewed by Yongbo Jia, MD (贾勇波), Deputy Director & Head of Dermatology. Last reviewed: 18 September 2026.

This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.